Medical - Pharmaceuticals
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
|---|---|---|---|---|---|---|
| 1 | NVS | Novartis AG ADR | 121.90 | -1.91 (-1.54%) | 257.50B | A |
| 2 | JNJ | Johnson & Johnson | 156.01 | 0.45 (0.29%) | 375.37B | A |
| 3 | TARO | Taro Pharmaceutical Industries Ltd. | 42.97 | 0.00 (0.00%) | 1.62B | NR |
| 4 | SNPHY | SANTEN PHARMACEUTICAL CO., LTD. | 11.75 | 0.21 (1.80%) | N/A | A |
| 5 | INDV | Indivior PLC | 15.41 | 0.01 (0.06%) | 2.12B | A |
| 6 | DSNKY | Daiichi Sankyo Company, Limited | 22.25 | -0.55 (-2.41%) | 42.15B | A |
| 7 | AZN | AstraZeneca PLC ADR | 69.45 | -1.68 (-2.36%) | 215.39B | A |
| 8 | CPIX | Cumberland Pharmaceuticals Inc. | 3.15 | -0.26 (-7.62%) | 47.13M | A |
| 9 | GSK | GSK PLC ADR | 38.18 | -0.33 (-0.86%) | 78.17B | A |
| 10 | RHHBY | Roche Holding AG ADR | 40.44 | -0.71 (-1.73%) | 257.92B | A |
| 11 | CPRX | Catalyst Pharmaceuticals, Inc. | 21.46 | 0.01 (0.05%) | 2.62B | A |
| 12 | ALPMY | Astellas Pharma Inc. ADR | 9.60 | -0.05 (-0.52%) | 17.37B | A |
| 13 | AUPH | Aurinia Pharmaceuticals Inc | 7.59 | 0.10 (1.34%) | 1.03B | A |
| 14 | NVO | Novo Nordisk A/S ADR | 69.17 | -0.65 (-0.93%) | 308.84B | A |
| 15 | BMY | Bristol-Myers Squibb Co. | 46.92 | -0.09 (-0.19%) | 95.49B | A |
| 16 | HZNP | Horizon Therapeutics PLC | 116.30 | 0.05 (0.04%) | 26.63B | NR |
| 17 | KMDA | Kamada Ltd. | 7.88 | 0.14 (1.81%) | 453.14M | A |
| 18 | ABBV | AbbVie Inc. | 189.28 | -1.47 (-0.77%) | 334.34B | A |
| 19 | CALT | Calliditas Therapeutics AB ADR | 40.00 | -0.16 (-0.40%) | 1.19B | A |
| 20 | AMRX | Amneal Pharmaceuticals, Inc. | 8.42 | 0.05 (0.60%) | 2.64B | A |
| 21 | BTMD | Biote Corp. | 4.22 | 0.03 (0.72%) | 230.88M | A |
| 22 | TEVA | Teva Pharmaceutical Industries Ltd. ADR | 17.01 | -0.04 (-0.23%) | 19.51B | B |
| 23 | OPHLY | ONO PHARMACEUTICAL CO., LTD. | 3.52 | -0.03 (-0.85%) | N/A | B |
| 24 | BAYRY | Bayer AG ADR | 7.67 | -0.11 (-1.41%) | 30.14B | B |
| 25 | NBIX | Neurocrine Biosciences, Inc. | 129.11 | -0.29 (-0.22%) | 12.78B | B |
| 26 | MRK | Merck & Co. Inc. | 80.93 | -1.46 (-1.77%) | 203.22B | B |
| 27 | SUPN | Supernus Pharmaceuticals, Inc. | 31.98 | -0.09 (-0.28%) | 1.79B | B |
| 28 | HLUYY | H. Lundbeck A/S | 22.00 | -0.01 (-0.02%) | 21.91B | NR |
| 29 | GRFS | Grifols, S.A. | 9.08 | -0.06 (-0.66%) | 6.24B | B |
| 30 | CRLBF | Cresco Labs Inc. | 0.50 | -0.01 (-2.06%) | 245.70M | B |
| 31 | PROC | Procaps Group, S.A. | 1.01 | -0.58 (-36.51%) | 113.95M | NR |
| 32 | ESAIY | Eisai Co. Ltd. ADR | 7.09 | 0.02 (0.28%) | N/A | B |
| 33 | COLL | Collegium Pharmaceutical, Inc. | 30.35 | -0.16 (-0.52%) | 975.21M | B |
| 34 | ZTS | Zoetis Inc. | 159.18 | 0.10 (0.06%) | 70.87B | B |
| 35 | ACIU | AC Immune SA | 2.07 | 0.05 (2.48%) | 207.85M | B |
| 36 | MEIP | MEI Pharma, Inc. | 2.68 | 0.28 (11.67%) | 17.85M | NR |
| 37 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 27.88 | 0.44 (1.60%) | 2.03B | B |
| 38 | SNY | Sanofi - ADR | 48.30 | -1.01 (-2.05%) | 118.45B | B |
| 39 | GDRX | GoodRx Holdings, Inc. | 4.71 | -0.34 (-6.73%) | 1.68B | B |
| 40 | PCRX | Pacira BioSciences, Inc. | 23.22 | 0.01 (0.04%) | 1.07B | B |
| 41 | RDY | Dr. Reddy's Laboratories Ltd | 15.08 | 0.20 (1.34%) | 12.59B | B |
| 42 | KPRX | Kiora Pharmaceuticals Inc. | 2.85 | -0.01 (-0.35%) | 8.68M | B |
| 43 | PSTX | Poseida Therapeutics Inc. | 9.50 | -0.06 (-0.63%) | 928.85M | B |
| 44 | CTMX | CytomX Therapeutics, Inc. | 2.50 | 0.02 (0.81%) | 201.55M | B |
| 45 | IPSEY | Ipsen S.A. | 30.01 | -0.14 (-0.46%) | 10.06B | B |
| 46 | JUSHF | Jushi Holdings Inc. | 0.32 | 0.02 (5.37%) | 62.92M | B |
| 47 | PFE | Pfizer Inc. | 25.38 | 0.06 (0.24%) | 144.29B | B |
| 48 | BHC | Bausch Health Companies Inc. | 7.06 | -0.06 (-0.84%) | 2.61B | B |
| 49 | SNOA | Sonoma Pharmaceuticals, Inc. | 2.97 | 0.05 (1.71%) | 4.88M | B |
| 50 | IRWD | Ironwood Pharmaceuticals, Inc. - | 0.77 | 0.03 (3.56%) | 123.95M | B |
| 51 | ACAD | ACADIA Pharmaceuticals Inc. | 20.95 | -0.29 (-1.37%) | 3.51B | B |
| 52 | RIGL | Rigel Pharmaceuticals, Inc. | 18.93 | 0.28 (1.50%) | 338.32M | B |
| 53 | HLN | Haleon PLC ADR | 10.25 | -0.01 (-0.10%) | 46.07B | B |
| 54 | LLY | Eli Lilly & Co. | 780.67 | 1.39 (0.18%) | 739.87B | C |
| 55 | ESALY | Eisai Co. Ltd. ADR | 61.51 | -1.33 (-2.11%) | 17.64B | NR |
| 56 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 8.93 | 0.12 (1.36%) | 863.88M | C |
| 57 | ELAN | Elanco Animal Health Incorporated | 14.64 | -0.08 (-0.54%) | 7.27B | C |
| 58 | AERI | Aerie Pharmaceuticals, Inc. | 15.25 | 0.01 (0.07%) | 753.61M | NR |
| 59 | CLLS | Cellectis S.A. | 1.58 | -0.07 (-4.24%) | 87.82M | C |
| 60 | AXSM | Axsome Therapeutics, Inc. | 105.44 | 1.53 (1.47%) | 5.19B | C |
| 61 | VRNOF | Verano Holdings Corp. | 0.49 | -0.01 (-2.78%) | 177.27M | C |
| 62 | AMPH | Amphastar Pharmaceuticals, Inc. | 23.20 | -0.38 (-1.61%) | 1.09B | C |
| 63 | VTRS | Viatris Inc. | 9.32 | -0.02 (-0.21%) | 10.94B | C |
| 64 | PRGO | Perrigo Co. PLC | 27.20 | -0.06 (-0.22%) | 3.74B | C |
| 65 | SNDL | Sundial Growers Inc. | 1.27 | 0.02 (1.60%) | 333.73M | C |
| 66 | GBIO | Generation Bio Inc. | 0.34 | 0.01 (1.51%) | 22.99M | C |
| 67 | XERS | Xeris Pharmaceuticals, Inc. | 4.75 | 0.02 (0.42%) | 742.83M | C |
| 68 | TAK | Takeda Pharmaceutical Co. Ltd. ADR | 15.34 | -0.08 (-0.52%) | 48.81B | C |
| 69 | SLGL | Sol-Gel Technologies Ltd. | 7.47 | 0.14 (1.91%) | 20.81M | NR |
| 70 | ENDP | Endo International PLC | 0.29 | -0.02 (-5.00%) | 68.80M | NR |
| 71 | GTBIF | Green Thumb Industries Inc. | 5.50 | -0.02 (-0.36%) | 1.16B | C |
| 72 | ARVN | Arvinas, Inc. | 7.95 | 0.05 (0.63%) | 580.28M | C |
| 73 | HYPMY | Hypera S.A. | 5.03 | 0.01 (0.12%) | 3.18B | C |
| 74 | ASMB | Assembly Biosciences, Inc. | 18.14 | -0.16 (-0.87%) | 138.55M | C |
| 75 | TCNNF | Trulieve Cannabis Corp. | 3.86 | 0.02 (0.52%) | N/A | C |
| 76 | EGRX | Eagle Pharmaceuticals, Inc. | 3.00 | 0.11 (3.63%) | 38.96M | C |
| 77 | ADMS | Adamas Pharmaceuticals, Inc. | 8.22 | 0.06 (0.74%) | 376.37M | NR |
| 78 | VRCA | Verrica Pharmaceuticals Inc. | 0.71 | 0.06 (9.01%) | 65.36M | C |
| 79 | WXXWY | WuXi Biologics (Cayman) Inc. | 6.45 | 0.01 (0.08%) | N/A | C |
| 80 | EVTCY | Evotec SE | 22.96 | -0.01 (-0.04%) | 7.58B | NR |
| 81 | SPRO | Spero Therapeutics, Inc. | 2.91 | 0.01 (0.34%) | 162.70M | C |
| 82 | SURF | Surface Oncology, Inc. | 1.07 | -0.01 (-0.93%) | 65.08M | NR |
| 83 | MGTA | Magenta Therapeutics, Inc. | 0.70 | -0.06 (-7.74%) | 42.44M | NR |
| 84 | FENC | Fennec Pharmaceuticals Inc. | 8.80 | 0.26 (3.04%) | 242.88M | C |
| 85 | CCHWF | Columbia Care Inc. | 0.94 | -0.20 (-17.25%) | N/A | NR |
| 86 | ASRT | Assertio Therapeutics, Inc. | 0.65 | -0.02 (-3.23%) | 62.54M | C |
| 87 | OGN | Organon & Co. | 9.96 | -0.19 (-1.87%) | 2.59B | C |
| 88 | PTPI | Petros Pharmaceuticals Inc. | 0.03 | 0.00 (0.29%) | 1.09M | C |
| 89 | CWBHF | Charlotte's Web Holdings, Inc. | 0.09 | -0.00 (-2.19%) | N/A | NR |
| 90 | MTEM | Molecular Templates, Inc. | 0.00 | 0.00 (0.00%) | 0.66K | NR |
| 91 | LPCN | Lipocine Inc. | 3.10 | -0.01 (-0.32%) | 16.59M | C |
| 92 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 1.11 | -0.02 (-1.77%) | 69.47M | NR |
| 93 | SMTI | Sanara MedTech Inc. | 29.65 | -0.29 (-0.97%) | 263.53M | C |
| 94 | PRLD | Prelude Therapeutics Inc. | 0.79 | -0.01 (-0.76%) | 44.82M | C |
| 95 | HOOK | HOOKIPA Pharma Inc. | 1.23 | 0.00 (0.00%) | 14.99M | C |
| 96 | APNHY | Aspen Pharmacare Holdings Limited | 6.99 | 0.22 (3.27%) | 3.12B | C |
| 97 | BFRA | Biofrontera AG | 2.67 | -0.28 (-9.49%) | 75.72M | NR |
| 98 | ALIM | Alimera Sciences, Inc. | 5.54 | -0.01 (-0.18%) | 290.24M | C |
| 99 | PTGX | Protagonist Therapeutics, Inc. | 51.05 | 0.36 (0.71%) | 3.16B | C |
| 100 | OPTN | OptiNose, Inc. | 9.60 | -0.11 (-1.13%) | 97.22M | C |
| 101 | GRVI | GROVE, INC. | 4.95 | 0.35 (7.61%) | 83.26M | NR |
| 102 | CUE | Cue Biopharma, Inc. | 0.70 | 0.00 (0.46%) | 52.38M | C |
| 103 | SYBX | Synlogic, Inc. | 1.18 | -0.02 (-1.67%) | 13.80M | NR |
| 104 | ITRM | Iterum Therapeutics plc - Ordinary Share | 0.96 | -0.00 (-0.42%) | 38.56M | C |
| 105 | ELOX | Eloxx Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 0.31K | NR |
| 106 | NEOS | Neos Therapeutics, Inc. | 1.15 | -0.03 (-2.54%) | 57.22M | NR |
| 107 | TXMD | TherapeuticsMD, Inc. | 1.18 | 0.04 (3.51%) | 13.66M | NR |
| 108 | RDHL | Redhill Biopharma Ltd. | 2.03 | 0.03 (1.50%) | 4.65M | C |
| 109 | YMAB | Y-mAbs Therapeutics, Inc. | 4.30 | 0.04 (0.94%) | 194.72M | C |
| 110 | BVXV | BiondVax Pharmaceuticals Ltd. | 1.36 | 0.05 (3.82%) | 2.54M | NR |
| 111 | TCDA | Tricida, Inc. | 0.11 | -0.01 (-10.00%) | 6.01M | NR |
| 112 | RMTI | Rockwell Medical, Inc. | 0.82 | 0.00 (0.56%) | 28.12M | C |
| 113 | HAPP | HAPPINESS BIOTECH GROUP LTD | 4.50 | 0.06 (1.35%) | 31.30M | NR |
| 114 | BFRI | Biofrontera Inc. | 0.70 | 0.01 (1.43%) | 6.61M | C |
| 115 | CURLF | Curaleaf Holdings, Inc. | 0.84 | 0.01 (0.78%) | 554.92M | C |
| 116 | ARCT | Arcturus Therapeutics Holdings Inc. | 13.78 | 0.16 (1.17%) | 373.73M | C |
| 117 | NVCR | Novocure Ltd. | 17.71 | -0.17 (-0.95%) | 1.97B | C |
| 118 | MTCR | Metacrine Inc. | 0.58 | -0.01 (-1.29%) | 24.75M | NR |
| 119 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 50.30 | 1.21 (2.46%) | 2.49B | C |
| 120 | SXTC | China SXT Pharmaceuticals, Inc. | 1.88 | 0.10 (5.62%) | 218.13M | C |
| 121 | MYOV | Myovant Sciences Ltd. Common Shares | 26.98 | -0.01 (-0.04%) | 2.62B | NR |
| 122 | IVA | Inventiva S.A. ADR | 3.01 | 0.03 (1.01%) | 287.94M | C |
| 123 | STRO | Sutro Biopharma, Inc. | 0.76 | -0.00 (-0.10%) | 64.46M | C |
| 124 | PYPD | PolyPid Ltd. | 3.50 | 0.01 (0.29%) | 35.67M | NR |
| 125 | ZGNX | Zogenix, Inc. | 26.68 | 0.42 (1.60%) | 1.50B | NR |
| 126 | ORTX | Orchard Therapeutics plc | 16.70 | 0.05 (0.30%) | 380.11M | NR |
| 127 | YCBD | cbdMD Inc. | 0.86 | -0.06 (-6.40%) | 7.66M | C |
| 128 | ERYP | Erytech Pharma S.A. | 0.78 | 0.00 (0.00%) | 26.61M | NR |
| 129 | ECOR | electroCore, Inc. | 6.11 | 0.76 (14.10%) | 45.34M | C |
| 130 | RYTM | Rhythm Pharmaceuticals, Inc. | 65.77 | -1.15 (-1.72%) | 4.18B | C |
| 131 | ETON | Eton Pharmaceuticals, Inc. | 14.45 | -0.03 (-0.21%) | 387.52M | C |
| 132 | CLSD | Clearside Biomedical, Inc. | 0.81 | 0.01 (0.78%) | 63.12M | C |
| 133 | IMAB | I-Mab ADR | 2.15 | -0.14 (-6.11%) | 175.57M | C |
| 134 | LYRA | Lyra Therapeutics Inc. | 9.00 | -0.31 (-3.33%) | 11.93M | C |
| 135 | LZAGY | Lonza Group AG ADR | 70.07 | -0.14 (-0.20%) | 50.61B | C |
| 136 | TKNO | Alpha Teknova, Inc. | 5.21 | 0.12 (2.36%) | 278.43M | C |
| 137 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 7.51 | 0.59 (8.53%) | 603.54M | C |
| 138 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 2.00 | 0.03 (1.52%) | 135.66M | NR |
| 139 | MDGL | Madrigal Pharmaceuticals, Inc. | 298.87 | -1.28 (-0.43%) | 6.64B | C |
| 140 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 1.42 | 0.00 (0.00%) | 45.46M | NR |
| 141 | IMCC | IM Cannabis Corp. | 2.96 | 0.32 (12.12%) | 11.97M | C |
| 142 | ODT | Odonate Therapeutics, Inc. | 1.12 | -0.05 (-4.27%) | 43.11M | NR |
| 143 | LCI | Lannett Co Inc | 0.69 | 0.03 (3.86%) | 7.38M | NR |
| 144 | UROV | Urovant Sciences Ltd. | 16.24 | 0.01 (0.06%) | 531.75M | NR |
| 145 | AYRWF | Ayr Strategies Inc. | 0.16 | -0.01 (-4.99%) | 18.59M | C |
| 146 | VYGR | Voyager Therapeutics, Inc. | 3.20 | 0.00 (0.00%) | 177.08M | C |
| 147 | RLAY | Relay Therapeutics Inc. | 3.63 | 0.03 (0.83%) | 622.35M | C |
| 148 | EOLS | Evolus, Inc. | 9.27 | 0.06 (0.65%) | 597.69M | C |
| 149 | FLXN | Flexion Therapeutics, Inc. | 25.08 | 0.00 (0.00%) | 1.26B | NR |
| 150 | CRXT | Clarus Therapeutics Holdings, Inc. | 0.05 | -0.02 (-31.16%) | 2.47M | NR |
| 151 | MOR | MorphoSys AG | 18.96 | 0.45 (2.43%) | 2.86B | C |
| 152 | NTRB | Nutriband Inc. | 9.91 | -0.81 (-7.56%) | 110.54M | C |
| 153 | CVSI | CV Sciences, Inc. | 0.04 | -0.00 (-2.65%) | 6.80M | NR |
| 154 | EPIX | ESSA Pharma Inc. | 1.74 | 0.04 (2.35%) | 77.24M | C |
| 155 | IONS | Ionis Pharmaceuticals, Inc. | 43.00 | -0.59 (-1.35%) | 6.84B | C |
| 156 | CTLT | Catalent Inc. | 63.48 | 0.00 (0.00%) | 11.52B | C |
| 157 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 2.23 | -0.06 (-2.62%) | 89.90M | C |
| 158 | CNTA | Centessa Pharmaceuticals Limited | 14.07 | 0.33 (2.40%) | 1.88B | C |
| 159 | HUGE | FSD Pharma Inc. | 0.09 | -0.01 (-10.10%) | 3.61M | NR |
| 160 | LHSIF | Liberty Health Sciences Inc. | 1.14 | -0.03 (-2.17%) | 392.01M | NR |
| 161 | SMMT | Summit Therapeutics plc | 24.55 | 1.93 (8.53%) | 18.23B | D |
| 162 | FIXX | Homology Medicines, Inc. | 0.93 | 0.01 (0.77%) | 54.34M | NR |
| 163 | TRVI | Trevi Therapeutics, Inc. | 5.95 | -0.03 (-0.50%) | 697.89M | D |
| 164 | FFNTF | 4Front Ventures Corp. | 0.00 | 0.00 (60.00%) | N/A | NR |
| 165 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 0.16 | -0.02 (-8.77%) | 12.11M | NR |
| 166 | ALXO | ALX Oncology Holdings Inc. | 0.46 | 0.02 (3.39%) | 24.57M | D |
| 167 | LSDI | Lucy Scientific Discovery Inc. | 0.51 | -0.16 (-23.29%) | 907.03K | NR |
| 168 | APLS | Apellis Pharmaceuticals, Inc. | 18.26 | 0.44 (2.47%) | 2.29B | D |
| 169 | ETTX | Entasis Therapeutics Holdings Inc. | 2.19 | -0.01 (-0.45%) | 104.80M | NR |
| 170 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 0.03 | 0.00 (2.03%) | 673.48K | D |
| 171 | RCEL | AVITA Medical, Inc. | 5.42 | 0.25 (4.84%) | 143.28M | D |
| 172 | TRSSF | TerrAscend Corp. | 1.72 | 0.00 (0.00%) | 433.20M | NR |
| 173 | SCYX | SCYNEXIS, Inc. | 0.73 | 0.01 (1.57%) | 28.54M | D |
| 174 | KALV | KalVista Pharmaceuticals, Inc. | 11.98 | 0.20 (1.70%) | 595.60M | D |
| 175 | TERN | Terns Pharmaceuticals, Inc. | 4.32 | 0.06 (1.41%) | 377.30M | D |
| 176 | CHMA | Chiasma, Inc. | 3.76 | -0.24 (-6.00%) | 217.68M | NR |
| 177 | ITOS | iTeos Therapeutics Inc. | 10.18 | 0.02 (0.20%) | 389.63M | D |
| 178 | MESO | Mesoblast Limited | 10.68 | -0.18 (-1.66%) | 1.36B | D |
| 179 | GLSI | Greenwich LifeSciences Inc. | 10.03 | 0.15 (1.52%) | 134.08M | D |
| 180 | ATNX | Athenex, Inc. | 0.20 | -0.06 (-23.39%) | 1.76M | NR |
| 181 | APTX | Aptinyx Inc. | 0.10 | 0.00 (3.11%) | 6.50M | NR |
| 182 | SCPH | scPharmaceuticals Inc. | 3.97 | -0.07 (-1.73%) | 209.58M | D |
| 183 | SLRX | Salarius Pharmaceuticals Inc | 0.89 | -0.01 (-1.17%) | 1.89M | D |
| 184 | NOVN | Novan, Inc. | 0.09 | -0.03 (-24.84%) | 2.64M | NR |
| 185 | ACRHF | Acreage Holdings, Inc. | 0.00 | -0.00 (-2.44%) | N/A | NR |
| 186 | MMNFF | MedMen Enterprises Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| 187 | MIST | Milestone Pharmaceuticals Inc. | 1.94 | 0.02 (1.04%) | 103.72M | D |
| 188 | OPNT | Opiant Pharmaceuticals, Inc. | 20.65 | -0.12 (-0.58%) | 106.64M | NR |
| 189 | HROW | Harrow Health, Inc. | 31.75 | 1.18 (3.86%) | 1.16B | D |
| 190 | KPTI | Karyopharm Therapeutics Inc. | 4.39 | -0.22 (-4.77%) | 37.93M | D |
| 191 | ALLO | Allogene Therapeutics, Inc. | 1.19 | -0.01 (-0.83%) | 260.29M | D |
| 192 | NVCT | Nuvectis Pharma Inc. | 7.54 | 0.02 (0.27%) | 157.54M | D |
| 193 | TYME | Tyme Technologies, Inc. | 0.31 | 0.02 (8.07%) | 53.50M | NR |
| 194 | PHAS | PhaseBio Pharmaceuticals, Inc. | 0.07 | -0.02 (-26.21%) | 3.50M | NR |
| 195 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 9.63 | -1.37 (-12.48%) | 8.65M | NR |
| 196 | RDUS | Radius Health, Inc. | 29.73 | 0.10 (0.34%) | 838.45M | D |
| 197 | SVRA | Savara, Inc. | 2.19 | 0.09 (4.29%) | 378.51M | D |
| 198 | AGRX | Agile Therapeutics, Inc. | 1.51 | 0.00 (0.00%) | 10.35M | NR |
| 199 | HRVSF | Harvest Health & Recreation Inc. | 3.22 | 0.03 (0.94%) | N/A | NR |
| 200 | SBFM | Sunshine Biopharma Inc. | 1.55 | -0.10 (-6.06%) | 7.06M | D |
| 201 | APM | Aptorum Group Limited - Class A Ordinary Shares | 0.96 | 0.04 (4.18%) | 5.13M | D |
| 202 | VERU | Veru Inc. | 0.61 | 0.02 (3.94%) | 88.92M | D |
| 203 | KALA | Kala Pharmaceuticals, Inc. | 5.10 | 0.05 (0.99%) | 32.91M | D |
| 204 | EVOK | Evoke Pharma, Inc. | 2.72 | 0.03 (1.12%) | 4.06M | NR |
| 205 | TENX | Tenax Therapeutics, Inc. | 5.81 | 0.07 (1.22%) | 24.10M | D |
| 206 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 6.95 | 0.20 (2.96%) | 1.08B | D |
| 207 | DRRX | DURECT Corporation | 0.67 | 0.00 (0.02%) | 20.70M | D |
| 208 | ACRS | Aclaris Therapeutics, Inc. | 1.44 | -0.01 (-0.69%) | 155.92M | D |
| 209 | HEXO | HEXO Corp. | 0.71 | 0.02 (2.45%) | 31.24M | NR |
| 210 | NYMX | Nymox Pharmaceutical Corporation | 0.20 | -0.05 (-19.68%) | 18.10M | NR |
| 211 | BKUH | Bakhu Holdings, Corp. | 0.02 | 0.00 (0.00%) | N/A | NR |
| 212 | BTAI | BioXcel Therapeutics, Inc. | 1.93 | 0.00 (0.00%) | 11.69M | D |
| 213 | REPL | Replimune Group, Inc. | 9.40 | -0.15 (-1.57%) | 724.62M | D |
| 214 | CMPI | Checkmate Pharmaceuticals Inc. | 10.50 | 0.02 (0.19%) | 231.40M | NR |
| 215 | ACRX | AcelRx Pharmaceuticals, Inc. | 0.86 | 0.06 (7.50%) | 14.58M | NR |
| 216 | CLDI | Calidi Biotherapeutics Inc. | 0.25 | 0.01 (5.09%) | 7.81M | D |
| 217 | RPTX | Repare Therapeutics Inc. | 1.44 | 0.00 (0.00%) | 61.76M | D |
| 218 | ALBO | Albireo Pharma, Inc. | 44.15 | -0.10 (-0.23%) | 913.95M | NR |
| 219 | GRAL | GRAIL Inc. | 46.72 | -0.84 (-1.77%) | 1.68B | D |
| 220 | FUSN | Fusion Pharmaceuticals Inc. | 21.55 | 0.03 (0.14%) | 1.83B | NR |
| 221 | ABEO | Abeona Therapeutics Inc. | 5.89 | 0.02 (0.34%) | 301.31M | D |
| 222 | ALNA | Allena Pharmaceuticals, Inc. | 0.08 | 0.00 (3.16%) | 9.16M | NR |
| 223 | GRAY | Graybug Vision Inc | 5.50 | -0.67 (-10.80%) | 8.64M | NR |
| 224 | BBIO | BridgeBio Pharma, Inc. | 43.99 | 1.16 (2.71%) | 8.35B | D |
| 225 | ARDS | Aridis Pharmaceuticals Inc. | 0.00 | 0.00 (0.00%) | 5.33K | NR |
| 226 | OGI | OrganiGram Holdings Inc. | 1.43 | 0.05 (3.62%) | 191.53M | D |
| 227 | ACER | Acer Therapeutics Inc. | 0.66 | -0.14 (-17.95%) | 16.15M | NR |
| 228 | EYPT | EyePoint Pharmaceuticals, Inc. | 9.72 | 0.06 (0.62%) | 668.84M | D |
| 229 | RETA | Reata Pharmaceuticals, Inc. - | 172.36 | 0.04 (0.02%) | 6.58B | NR |
| 230 | HOTH | Hoth Therapeutics, Inc. | 1.21 | 0.01 (0.83%) | 15.98M | D |
| 231 | APLT | Applied Therapeutics, Inc. | 0.32 | -0.02 (-5.41%) | 45.30M | D |
| 232 | IMRN | Immuron Limited | 1.78 | 0.08 (4.41%) | 10.38M | NR |
| 233 | ORGS | Orgenesis Inc. | 1.33 | -0.20 (-13.07%) | 6.38M | D |
| 234 | ZYNE | Zynerba Pharmaceuticals, Inc. | 1.30 | 0.03 (2.36%) | 70.12M | NR |
| 235 | MLYS | Mineralys Therapeutics Inc. | 14.54 | 0.24 (1.68%) | 947.64M | D |
| 236 | ACB | Aurora Cannabis Inc. | 4.54 | 0.07 (1.57%) | 255.21M | D |
| 237 | EYEN | Eyenovia, Inc. | 15.82 | 5.26 (49.81%) | 45.61M | D |
| 238 | SNDX | Syndax Pharmaceuticals, Inc. | 9.00 | 0.00 (0.00%) | 774.42M | D |
| 239 | SNES | SenesTech, Inc. | 5.14 | 0.07 (1.38%) | 11.55M | D |
| 240 | JUVAF | Juva Life Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| 241 | CRNX | Crinetics Pharmaceuticals, Inc. | 29.80 | 0.36 (1.22%) | 2.79B | D |
| 242 | PCVX | Vaxcyte Inc. | 33.25 | -0.02 (-0.06%) | 4.29B | D |
| 243 | ATXI | Avenue Therapeutics, Inc. | 0.34 | 0.08 (31.80%) | 1.08M | D |
| 244 | DNLI | Denali Therapeutics Inc. | 14.69 | -0.21 (-1.41%) | 2.13B | D |
| 245 | ADIL | Adial Pharmaceuticals, Inc | 0.33 | -0.00 (-0.97%) | 3.41M | D |
| 246 | CMPS | COMPASS Pathways PLC ADR | 3.26 | -0.12 (-3.55%) | 305.01M | D |
| 247 | VTVT | vTv Therapeutics Inc. - | 15.07 | 0.01 (0.07%) | 48.15M | D |
| 248 | CKPT | Checkpoint Therapeutics, Inc. | 4.26 | 0.03 (0.71%) | 370.71M | D |
| 249 | SNGX | Soligenix, Inc. | 1.20 | -0.06 (-4.76%) | 3.92M | D |
| 250 | LQDA | Liquidia Technologies, Inc. | 12.19 | 0.13 (1.08%) | 1.04B | D |
| 251 | CNSP | CNS PHARMACEUTICALS, INC. | 0.92 | -0.02 (-2.12%) | 5.03M | D |
| 252 | IDYA | IDEAYA Biosciences, Inc. | 22.10 | 0.18 (0.82%) | 1.94B | D |
| 253 | TLRY | Tilray Brands Inc. Cl 2 | 0.54 | 0.05 (11.03%) | 542.20M | F |
| 254 | VREOF | Vireo Health International, Inc. | 0.42 | -0.02 (-4.16%) | 144.03M | NR |
| 255 | ANVS | Annovis Bio Inc. | 2.36 | -0.02 (-0.84%) | 45.99M | F |
| 256 | RFL | Rafael Holdings, Inc. Class B | 1.89 | 0.01 (0.53%) | 66.32M | NR |
| 257 | RGC | Regencell Bioscience Holdings Ltd. | 22.99 | 12.63 (121.91%) | 11.37B | D |
| 258 | CNST | Constellation Pharmaceuticals, Inc. | 33.99 | 0.02 (0.06%) | 1.63B | NR |
| 259 | GPCR | Structure Therapeutics Inc. ADR | 20.36 | -0.08 (-0.37%) | 1.17B | F |
| 260 | BGXX | Bright Green Corp. | 0.04 | -0.00 (-2.56%) | 7.26M | NR |
| 261 | ACST | Acasti Pharma, Inc. - | 3.37 | -0.03 (-0.88%) | 31.67M | NR |
| 262 | CDT | Conduit Pharmaceuticals Inc. | 2.92 | 0.12 (4.29%) | 2.33M | F |
| 263 | NNOX | Nano-X Imaging Ltd. | 5.32 | -0.01 (-0.19%) | 307.38M | F |
| 264 | ZOM | Zomedica Corp. | 0.10 | -0.00 (-0.21%) | 95.35M | NR |
| 265 | VKTX | Viking Therapeutics, Inc. | 28.19 | 0.47 (1.70%) | 3.17B | F |
| 266 | CDMO | Avid Bioservices, Inc. | 12.49 | 0.01 (0.08%) | 798.90M | F |
| 267 | CGC | Canopy Growth Corporation | 1.28 | 0.09 (7.56%) | 235.35M | F |
| 268 | SHOT | Safety Shot Inc. | 0.37 | -0.04 (-8.69%) | 27.82M | F |
| 269 | PRFX | PainReform Ltd. | 1.40 | 0.00 (0.00%) | 2.82M | F |
| NR | CBDHF | HempFusion Wellness Inc. | 0.00 | 0.00 (900.00%) | N/A | NR |
| NR | KHRNF | Khiron Life Sciences Corp. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | ANTCF | Aion Therapeutic Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
| NR | MJNA | Medical Marijuana Inc. | 0.00 | -0.00 (-33.33%) | N/A | NR |
| NR | GDTC | CytoMed Therapeutics Ltd. | 2.20 | 0.08 (3.61%) | 24.07M | NR |
| NR | ICNAF | Icanic Brands Company Inc. | 0.06 | 0.00 (0.00%) | N/A | NR |
| NR | SLGWF | SLANG Worldwide Inc. | 0.00 | -0.00 (-24.39%) | N/A | NR |
| NR | ACUR | Acura Pharmaceuticals | 0.00 | -0.00 (-92.00%) | 13.30K | NR |
| NR | TLC | Taiwan Liposome Company, Ltd. - ADRs | 7.00 | 0.00 (0.00%) | 294.54M | NR |
| NR | ZEAL | Zealand Pharma A/S | 17.59 | 0.21 (1.21%) | 818.60M | NR |
| NR | EIDX | Eidos Therapeutics, Inc. | 122.21 | -6.23 (-4.85%) | 4.75B | NR |
| NR | RXRX | Recursion Pharmaceuticals Inc. | 5.27 | 0.06 (1.15%) | 2.14B | F |
All price changes on this page include dividends and splits.